ການເງິນ
ການເງິນ
ໜ້າທຳອິດDTIL • NASDAQ
Precision BioSciences Inc
$4,09
21 ມ.ກ., 11 ໂມງ 29 ນາທີ 50 ວິນາທີ GMT-5 · USD · NASDAQ · ຂໍ້ຈຳກັດຄວາມຮັບຜິດຊອບ
ປິດກ່ອນໜ້າ
$4,17
ຂອບເຂດລາຄາໃນມື້
$4,06 - $4,17
ຂອບເຂດລາຄາໃນປີ
$3,75 - $8,82
ມູນຄ່າຮຸ້ນຕາມລາຄາຕະຫຼາດ
93,54 ລ້ານ USD
ປະລິມານສະເລ່ຍ
244,04 ພັນ
ອັດຕາ P/E
-
ເງິນປັນຜົນ
-
ຕະຫຼາດຂັ້ນຕົ້ນ
NASDAQ
ຂ່າວຕະຫຼາດ
Bloomberg.com
49 ນາທີກ່ອນ
Watch NYSE CEO on US Capital Markets, Trading Models
MarketBeat
12 ນາທີກ່ອນ
Humacyte (NASDAQ:HUMA) Given New $10.00 Price Target at Benchmark
HUMA
0,49%
Yahoo Finance UK
40 ນາທີກ່ອນ
Stock market today: Dow, S&P 500, Nasdaq jump after brutal sell-off as Trump rules out force on Greenland
.INX
1,03%
.DJI
0,95%
NDAQ
0,80%
Axios
6 ຊົ່ວໂມງກ່ອນ
Trump 2.0 stock market underperforms Trump 1.0
TipRanks
1 ຊົ່ວໂມງກ່ອນ
Currenc Group Discloses Nasdaq Deficiency Notice Over Delayed Annual Meeting
NDAQ
0,80%
CURR
1,25%
AP News
18 ຊົ່ວໂມງກ່ອນ
Wall Street sinks as Trump threatens 8 European countries with tariffs over Greenland
ກ່ຽວກັບ
Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform. Wikipedia
ສ້າງຕັ້ງ
2006
ເວັບໄຊ
precisionbiosciences.com
ພະນັກງານ
67
ຄົ້ນຫາ
ລຶບລ້າງການຊອກຫາ
ປິດການຊອກຫາ
ແອັບຂອງ Google
ເມນູຫຼັກ